OptimizeRx Corp — Director's Dealing 2010

Sep 15, 2010

SEC Form 4/A — Form 4/A

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2010-04-19

Reporting Person: Harrell David (Director, Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-04-19	Common Stock	J	300000	—	Disposed	3536250	Direct

Footnotes

F1: Mr. Harrell never acquired 300,000 shreas of common stock in lieu of technicial contributions.